Abstract
Background
We previously demonstrated that exogenous application of bone morphogenetic protein 7 (BMP7) reduced 6-hydroxydopamine-mediated neurodegeneration in a rodent model of Parkinson’s disease. The purpose of this study is to examine the endogenous neurotrophic properties of BMP Receptor II in dopaminergic neurons of the nigrostriatal pathway.
Methods
Adult male BMPRII dominant negative (BMPRIIDN) mice and their wild type controls (WT) were placed in the activity chambers for 3 days to monitor locomotor activity. Animals were sacrificed for tyrosine hydroxylase (TH) immunostaining. A subgroup of BMPRIIDN and WT mice were injected with high doses of methamphetamine (MA) and were sacrificed for terminal deoxy-nucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) histochemistry at 4 days after injection.
Results
BMPRIIDN mice had lower locomotor activity than the WT. There is a significant decrease in TH neuronal number in substantia nigra compacta, TH fiber density in the substantia nigra reticulata, and TH immunoreactivity in striatum in the BMPRIIDN mice, suggesting that deficiency in endogenous BMP signaling reduces dopaminergic innervation and motor function in the nigrostriatal pathway. Administration of MA increased TUNEL labeling in the substantia nigra in the BMPRIIDN mice.
Conclusions
Endogenous BMPs have trophic effects on nigrostriatal dopaminergic neurons. Deficiency in BMP signaling increases vulnerability to insults induced by high doses of MA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Althini S, Bengtsson H, Usoskin D, Söderström S, Kylberg A, Lindqvist E, Chuva de Sousa LS, Olson L, Lindeberg J, Ebendal T (2003) Normal nigrostriatal innervation but dopamine dysfunction in mice carrying hypomorphic tyrosine hydroxylase alleles. J Neurosci Res 72: 444–453
Chen HL, Lein PJ, Wang JY, Gash D, Hoffer BJ, Chiang YH (2003) Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Res 994: 81–90
Chou J, Lu Y, Kuo CC, Powers K, Shen H, Harvey BK, Hoffer BJ, and Wang Y (2007) Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neurosci (in press)
Deng X, Wang Y, Chou J, Cadet JL (2001) Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Mol Brain Res 93: 64–69
Harvey BK, Mark A, Chou J, Chen GJ, Hoffer BJ, Wang Y (2004) Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson’s disease. Brain Res 1022: 88–95
Koike K, Hashimoto K, Fukami G, Okamura N, Zhang L, Ohgake S, Koizumi H, Matsuzawa D, Kawamura N, Shimizu E, Iyo M (2005) The immunophilin ligand FK506 protects against methamphet-amine-induced dopaminergic neurotoxicity in mouse striatum. Neuropharmacology 48: 391–397
Lee JY, Koh HC, Chang MY, Park CH, Lee YS, Lee SH (2003) Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors. Neuroreport 14: 1401–1404
Lein P, Johnson M, Guo X, Rueger D, Higgins D (1995) Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons. Neuron 15: 597–605
Soderstrom S, Bengtsson H, Ebendal T (1996) Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell Tissue Res 286: 269–279
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag
About this paper
Cite this paper
Chou, J., Harvey, B.K., Ebendal, T., Hoffer, B., Wang, Y. (2008). Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice. In: Chiu, WT., et al. Reconstructive Neurosurgery. Acta Neurochirurgica Supplementum, vol 101. Springer, Vienna. https://doi.org/10.1007/978-3-211-78205-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-211-78205-7_16
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-78204-0
Online ISBN: 978-3-211-78205-7
eBook Packages: MedicineMedicine (R0)